Bile acid malabsorption in chronic diarrhea: Pathophysiology and treatment

Canadian Journal of Gastroenterology

Volumn 27, Issue 11, 2013, Pages 653-659

  Barkun, Alan ^a   Love, Jonathan ^b   Gould, Michael ^c   Pluta, Henryk ^d   Hillary Steinhart, A ^e  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c Toronto Digestive Disease Associates   (Canada)

^d Gastroenterology and Hepatology Clinic   (Canada)

^e UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Bile acid malabsorption; Cholestyramine; Chronic diarrhea; Enterohepatic circulation; FGF19; SeHCAT

Indexed keywords

BILE ACID; COLESEVELAM; COLESTIPOL; COLESTYRAMINE;

ABDOMINAL CRAMP; ABDOMINAL PAIN; BILE ACID MALABSORPTION; BLOATING; CHOLECYSTECTOMY; CHRONIC DIARRHEA; CONSTIPATION; CROHN DISEASE; DIARRHEA; DYSPEPSIA; ENTEROHEPATIC CIRCULATION; FLATULENCE; HEARTBURN; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; ILEUM DYSFUNCTION; IRRITABLE COLON; MALABSORPTION; NAUSEA; NAUSEA AND VOMITING; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; VAGOTOMY;

ALLYLAMINE; ANIMALS; ANION EXCHANGE RESINS; BILE ACIDS AND SALTS; CHOLESTYRAMINE RESIN; CHRONIC DISEASE; COLESTIPOL; DIARRHEA; HUMANS; MALABSORPTION SYNDROMES; PRACTICE GUIDELINES AS TOPIC; PREVALENCE;

EID: 84887243898     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/2013/485631     Document Type: Review

References (82)

1. Thomas PD, Forbes A, Green J, et al. Guidelines for the investigation of chronic diarrhoea, 2nd edn. Gut 2003;52(Suppl V):v1-v15.
2. Talley NJ, Weaver AL, Zinsmeister AR, Melton LJ III. Onset and disappearance of gastrointestinal symptoms and functional gastrointestinal disorders. Am J Epidemiol 1992;136:165-77.
3. Talley NJ, O'Keefe EA, Zinsmeister AR, Melton LJ III. Prevalence of gastrointestinal symptoms in the elderly: A population-based study. Gastroenterology 1992;102:895-901.
4. Schiller LR. Diarrhea and malabsorption in the elderly. Gastroenterol Clin North Am 2009;38:481-502.
5. Canadian Digestive Health Foundation. Diarrhea information sheet. (Accessed August 15, 2012).
6. Small DM, Dowling RH, Redinger RN. The enterohepatic circulation of bile salts. Arch Intern Med 1972;130:552-73.
7. Redinger RN. The role of the enterohepatic circulation of bile salts and nuclear hormone receptors in the regulation of cholesterol homeostasis: Bile salts as ligands for nuclear hormone receptors. Can J Gastroenterol 2003;17:265-71.
8. Fuchs M. Bile acid regulation of hepatic physiology: III. Regulation of bile acid synthesis: Past progress and future challenges. Am J Physiol Gastrointest Liver Physiol 2003;284:G551-7.
9. Swell L, Gustafsson J, Schwartz CC, Halloran LG, Danielsson H, Vlahcevic ZR. An in vivo evaluation of the quantitative significance of several potential pathways to cholic and chenodeoxycholic acids from cholesterol in man. J Lipid Res 1980;21:455-66.
10. Martínez-Augustin O, Sánchez de Medina F. Intestinal bile acid physiology and pathophysiology. World J Gastroenterol 2008;14:5630-40.
11. Lu TT, Makishima M, Repa JJ, et al. Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors. Mol Cell 2000;6:507-15.
12. Kim I, Ahn SH, Inagaki T, et al. Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine. J Lipid Res 2007;48:2664-72.
13. Craddock AL, Love MW, Daniel RW, et al. Expression and transport properties of the human ileal and renal sodium-dependent bile acid transporter. Am J Physiol 1998;274:G157-69.
14. Song KH, Li T, Owsley E, Strom S, Chiang JY. Bile acids activate fibroblast growth factor 19 signaling in human hepatocytes to inhibit cholesterol 7alpha-hydroxylase gene expression. Hepatology 2009;49:297-305.
15. Zweers SJ, Booij KA, Komuta M, et al. The human gallbladder secretes fibroblast growth factor 19 into bile: Towards defining the role of fibroblast growth factor 19 in the enterobiliary tract. Hepatology 2012;55:575-83.
16. Thomas LA, Veysey MJ, Bathgate T, et al. Mechanism for the transit-induced increase in colonic deoxycholic acid formation in cholesterol cholelithiasis. Gastroenterology 2000;119:806-15.
17. Stadler J, Stern HS, Yeung KS, et al. Effect of high fat consumption on cell proliferation activity of colorectal mucosa and on soluble faecal bile acids. Gut 1988;29:1326-31.
18. Hardison WG. Hepatic taurine concentration and dietary taurine as regulators of bile acid conjugation with taurine. Gastroenterology 1978;75:71-5.
19. Jung D, Fantin AC, Scheurer U, Fried M, Kullak-Ublick GA. Human ileal bile acid transporter gene ASBT (SLC10A2) is transactivated by the glucocorticoid receptor. Gut 2004;53:78-84.
20. Garbutt JT, Kenney TJ. Effect of cholestyramine on bile acid metabolism in normal man. J Clin Invest 1972;51:2781-9.
21. Chadwick VS, Gaginella TS, Carlson GL, Debongnie JC, Phillips SF, Hofmann AF. Effect of molecular structure on bile acid-induced alterations in absorptive function, permeability, and morphology in the perfused rabbit colon. J Lab Clin Med 1979;94:661-74.
22. Mekhjian HS, Phillips SF, Hofmann AF. Colonic secretion of water and electrolytes induced by bile acids: Perfusion studies in man. J Clin Invest 1971;50:1569-77.
23. Bajor A, Gillberg PG, Abrahamsson H. Bile acids: Short and long term effects in the intestine. Scand J Gastroenterol 2010;45:645-64.
24. Chiang JY. Bile acids: Regulation of synthesis. J Lipid Res 2009;50:1955-66.
25. Mekhjian HS, Phillips SF, Hofmann AF. Colonic absorption of unconjugated bile acids: Perfusion studies in man. Dig Dis Sci 1979;24:545-50.
26. McJunkin B, Fromm H, Sarva RP, Amin P: Factors in the mechanism of diarrhea in bile acid malabsorption: Fecal pH-a key determinant. Gastroenterology 1981;80:1454-1464.
27. Pattni S, Walters JRF. Recent advances in the understanding of bile acid malabsorption. Br Med Bull 2009;92:79-93.
28. Khalid U, Lalji A, Stafferton R, Andreyev J. Bile acid malabsoption: A forgotten diagnosis? Clin Med 2010;10:124-6.
29. Sadik R, Abrahamsson H, Ung KA, Stotzer PO. Accelerated regional bowel transit and overweight shown in idiopathic bile acid malabsorption. Am J Gastroenterol 2004;99:711-8.
30. van Tilburg AJ, de Rooij FW, van den Berg JW, van Blankenstein M. Primary bile acid malabsorption: A pathophysiologic and clinical entity? Scand J Gastroenterol (Suppl) 1992;194:66-70.
31. Törnblom H, Van Oudenhove L, Sadik R, Abrahamsson H, Tack J, Simrén M. Colonic transit time and IBS symptoms: What's the link? Am J Gastroenterol 2012;107:754-60.
32. Sciarretta G, Fagioli G, Furno A, et al. 75Se HCAT test in the detection of bile acid malabsorption in functional diarrhoea and its correlation with small bowel transit. Gut 1987;28:970-5.
33. Wong BS, Camilleri M, Carlson PJ, et al. A Klothoβ variant mediates protein stability and associates with colon transit in irritable bowel syndrome with diarrhea. Gastroenterology 2011;140:1934-42.
34. Wong BS, Camilleri M, Carlson P, et al. Increased bile acid biosynthesis is associated with irritable bowel syndrome with diarrhea. Clin Gastroenterol Hepatol 2012;10:1009-15.
35. Walters JR, Tasleem AM, Omer OS, Brydon WG, Dew T, le Roux CW. A new mechanism for bile acid diarrhea: Defective feedback inhibition of bile acid biosynthesis. Clin Gastroenterol Hepatol 2009;7:1189-94.
36. Grundy SM, Ahrens EH Jr, Miettinen TA. Quantitative isolation and gas-liquid chromatographic analysis of total fecal bile acids. J Lipid Res 1965;6:397-410.
37. Porter JL, Fordtran JS, Santa Ana CA, et al. A simple and accurate enzymatic method for measurement of total fecal bile acids in patients with severe fat malabsorption. J Lab Clin Med 2003;141:411-8.
38. Fromm H, Hofmann AF. Breath test for altered bile acid metabolism. Lancet 1971;ii:621-5.
39. Balzer K, Breuer N, Quebe-Fehling E. [Postprandial serum bile acid level and 75SeHCAT retention in diagnosis of bile acid malabsorption syndrome. A comparative study]. Med Klin (Munich) 1993;88(Suppl 1):23-8.
40. Sciarretta G, Vicini G, Fagioli G, Verri A, Ginevra A, Malaguti P. Use of 23-selena-25-homocholyltaurine to detect bile acid malabsorption in patients with illeal dysfunction or diarrhea. Gastroenterology 1986;91:1-9.
41. Boyd GS, Merrick MV, Monks R, et al. Se-75-labelled bile acid analogs, new radiopharmaceuticals for investigating the enterohepatic circulation. J Nuci Med 1981;22:720-5.
42. Nyhlin H, Merrick MV, Eastwood MA, Brydon WG. Evaluation of ileal function using 23-selena-25-homotaurocholate, a γ-labelled conjugated bile acid. Gastroenterology 1983; 84:63-8.
43. Bajor A, Kilander A, Sjövall H, Rudling M, Ung KA. The bile acid turnover rate assessed with the (75)SeHCAT test is stable in chronic diarrhoea but slightly decreased in healthy subjects after a long period of time. Dig Dis Sci 2008;53:2935-40.
44. Gälman C, Arvidsson T, Angelin B, Rudling M. Monitoring hepatic cholesterol 7 alpha-hydroxylase activity by assay of the stable bile acid intermediate 7 alpha-hydroxy-4-cholesten-3-one in peripheral blood. J Lipid Res 2003;44:859-66.
45. Eusufzai S, Axelson M, Angelin B, Einarsson K. Serum 7 alphahydroxy-4-cholesten-3-one concentrations in the evaluation of bile acid malabsorption in patients with diarrhoea: Correlation to SeHCAT test. Gut 1993;34:698-701.
46. Sauter GH, Munzing W, von Ritter C, Paumgartner G. Bile acid malabsorption a cause of chronic diarrhea: Diagnostic value of 7alpha-hydroxy-4-cholest-3-one in serum. Dig Dis Sci 1999;44:14-9.
47. Brydon WG, Culbert P, Kingstone K, et al. An evaluation of the use of serum 7-alpha-hydroxycholestenone as a diagnostic test of bile acid malabsorption causing watery diarrhea. Can J Gastroenterol 2011;25:319-23.
48. American Gastroenterological Association medical position statement: Guidelines for the evaluation and management of chronic diarrhea. Gastroenterology 1999;116:1461-3.
49. Borghede MK, Schlütter JM, Agnholt JS, Christensen LA, Gormsen LC, Dahlerup JF. Bile acid malabsorption investigated by selenium-75-homocholic acid taurine ((75)SeHCAT) scans: Causes and treatment responses to cholestyramine in 298 patients with chronic watery diarrhoea. Eur J Intern Med 2011;22:e137-40.
50. Lenicek M, Duricova D, Komarek V, et al. Bile acid malabsorption in inflammatory bowel disease: Assessment by serum markers. Inflamm Bowel Dis 2011;17:1322-7.
51. Kunstár E, Hegyi P, Rakonczay Jr Z, et al. Is bile acid malabsorption really a common feature of Crohn's disease or is it simply a consequence of ileal resection? Front Physiol 2011;2:28.
52. Nyhlin H, Merrick MV, Eastwood MA. Bile acid malabsorption in Crohn's disease and indications for its assessment using SeHCAT. Gut 1994;35:90-3.
53. Ford GA, Preece JD, Davies IH, Wilkinson SP. Use of the SeHCAT test in the investigation of diarrhea. Postgrad Med J 1992;68:272-6.
54. Sinha L, Liston R, Testa HJ, Moriarty KJ. Idiopathic bile acid malabsorption: Qualitative and quantitative clinical features and response to cholestyramine. Aliment Pharmacol Ther 1998;12:839-44.
55. Sciarretta G, Bonazzi L, Monti M, et al. Bile acid malabsorption in AIDS-associated chronic diarrhea: A prospective 1-year study. Am J Gastroenterol 1994;89:379-81.
56. Cramp ME, Hing MC, Marriott DJ, Freund J, Cooper DA. Bile acid malabsorption in HIV infected patients with chronic diarrhoea. Aust N Z J Med 1996;26:368-71.
57. Ung KA, Kilander AF, Lindgren A, Abrahamsson H. Impact of bile acid malabsorption on steatorrhoea and symptoms in patients with chronic diarrhoea. Eur J Gastroenterol Hepatol 2000;12:541-7.
58. Smith MJ, Cherian P, Raju GS, Dawson BF, Mahon S, Bardhan KD. Bile acid malabsorption in persistent diarrhoea. J R Coll Physicians Lond 2000;34:448-51.
59. Wildt S, Nørby Rasmussen S, Lysgård Madsen J, Rumessen JJ. Bile acid malabsorption in patients with chronic diarrhoea: Clinical value of SeHCAT test. Scand J Gastroenterol 2003;38:826-30.
60. Müller M, Willén R, Stotzer PO. Colonoscopy and SeHCAT for investigation of chronic diarrhea. Digestion 2004;69:211-8.
61. Fernández-Bañares F, Esteve M, Salas A, et al. Systematic evaluation of the causes of chronic watery diarrhea with functional characteristics. Am J Gastroenterol 2007;102:2520-8.
62. Wedlake L, A'Hern R, Russell D, Thomas K, Walters JR, Andreyev HJ. Systematic review: The prevalence of idiopathic bile acid malabsorption as diagnosed by SeHCAT scanning in patients with diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther 2009;30:707-17.
63. Kurien M, Evans KE, Leeds JS, Hopper AD, Harris A, Sanders DS. Bile acid malabsorption: An under-investigated differential diagnosis in patients presenting with diarrhea predominant irritable bowel syndrome type symptoms. Scand J Gastroenterol 2011;46:818-22.
64. Gracie DJ, Kane JS, Mumtaz S, Scarsbrook AF, Chowdhury FU, Ford AC. Prevalence of, and predictors of, bile acid malabsorption in outpatients with chronic diarrhea. Neurogastroenterol Motil 2012;24:983-e538.
65. Niaz SK, Sandrasegaran K, Renny FH, Jones BJ. Postinfective diarrhoea and bile acid malabsorption. J R Coll Physicians Lond 1997;31:53-6.
66. Menon S, Jones BJ. Postinfective bile acid malabsorption: Is this a long-term condition? Eur J Gastroenterol Hepatol 2011;23:308-10.
67. Nakamura T, Kikuchi H, Takebe K, et al. Correlation between bile acid malabsorption and pancreatic exocrine dysfunction in patients with chronic pancreatitis. Pancreas 1994;9:580-4.
68. Lanzini A, Lanzarotto F. Review article: The 'mechanical pumps' and the enterohepatic circulation of bile acids-defects in coeliac disease. Aliment Pharmacol Ther 2000;14(Suppl 2):58-61.
69. Sciarretta G, Furno A, Mazzoni M, Malaguti P. Postcholecystectomy diarrhea: Evidence of bile acid malabsorption assessed by SeHCAT test. Am J Gastroenterol 1992;87:1852-4.
70. Sauter GH, Moussavian AC, Meyer G, Steitz HO, Parhofer KG, Jüngst D. Bowel habits and bile acid malabsorption in the months after cholecystectomy. Am J Gastroenterol 2002;97:1732-5.
71. Stein TA, Nilsson LO, Burns GP, Mandell C, Wise L. Changes in bile salt composition after cholecystectomy and ileal resection. Am J Surg 1985;150:361-4.
72. al-Hadrani A, Lavelle-Jones M, Kennedy N, Neill G, Sutton D, Cuschieri A. Bile acid malabsorption in patients with postvagotomy diarrhoea. Ann Chir Gynaecol 1992;81:351-3.
73. Canadian Digestive Health Foundation. Irritable bowel syndrome. (Accessed September 10, 2012).
74. Luman W, Williams AJ, Merrick MV, Eastwood MA. Idiopathic bile acid malabsorption: Long-term outcome. Eur J Gastroenterol Hepatol 1995;7:641-5.
75. Olestyr (cholestyramine) Product Monograph. Pendopharm, Division of Pharmascience Inc, February 20, 2012.
76. Colestid (colestipol) Product Monograph. Pfizer Canada Inc., November 6, 2012.
77. Lodalis (colesevelam) Product Monograph. Valeant Canada LP, December 22, 2011.
78. Odunsi-Shiyanbade ST, Camilleri M, McKinzie S, et al. Effects of chenodeoxycholate and a bile acid sequestrant, colesevelam, on intestinal transit and bowel function. Clin Gastroenterol Hepatol 2010;8:159-65.
79. Wedlake L, Thomas K, Lalji A, Anagnostopoulos C, Andreyev HJ. Effectiveness and tolerability of colesevelam hydrochloride for bileacid malabsorption in patients with cancer: A retrospective chart review and patient questionnaire. Clin Ther 2009;31:2549-58.
80. Walters JRF, Pattni SS. Managing bile acid diarrhea. Ther Adv Gastroenterol 2010;3:349-57.
81. West RJ, Lloyd JK. The effect of cholestyramine on intestinal absorption. Gut 1975;16:93-8.
82. Jacobson TA, Armani A, McKenney JM, Guyton JR. Safety considerations with gastrointestinally active lipid-lowering drugs. Am J Cardiol 2007;99:47C-55C.